Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Pharmaceuticals

Allergic rhinitis

Allergic rhinitis (AR) is a symptomatic disorder of the nose induced after allergen exposure due to an IgE-mediated inflammation of the membranes lining the nose. It is characterized by nasal symptoms including anterior or posterior rhinorrhea, sneezing, nasal blockage and/or itching of the nose and it is often accompanied by ocular symptoms (redness, itching, burning, watery eyes). Furthermore, AR is a common comorbidity of asthma that contributes to its development and severity.

AR is subdivided into "intermittent" or "persistent" disease; the severity of the disease can be classified as "mild" or "moderate/severe". The burden of AR is often under-estimated since the disease is not life-threatening; however, it adversely affects many aspects of daily life such as the quality of sleep, school/work performances, daily life.